Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-17-051470

CEO and Director bought 37,736 shares at $2.65 ($100,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MENDLEIN JOHN CEO and Director 2017-08-31 Purchase +37,736 $2.65 $100,000 367,883 D
Derivatives
MENDLEIN JOHN CEO and Director 2017-08-31 Purchase · Warrant to Purchase Common Stock +14,151 14,151 D
Open-market purchases · 37,736 sh · avg $2.65 · $100,000
Loading xslF345X03/doc4.xml…